Cargando…
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is the leading cause of death among patients with IPF. However, there is no established treatment for this condition. Hence, we aimed to investigate the effectiveness and safety of recombinant human soluble thrombomodulin (rTM)...
Autores principales: | Awano, Nobuyasu, Jo, Taisuke, Izumo, Takehiro, Inomata, Minoru, Morita, Kojiro, Matsui, Hiroki, Fushimi, Kiyohide, Urushiyama, Hirokazu, Nagase, Takahide, Yasunaga, Hideo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908698/ https://www.ncbi.nlm.nih.gov/pubmed/35264250 http://dx.doi.org/10.1186/s40560-022-00608-5 |
Ejemplares similares
-
Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
por: Awano, Nobuyasu, et al.
Publicado: (2023) -
Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Awano, Nobuyasu, et al.
Publicado: (2021) -
Effect of nintedanib on acute exacerbations of fibrosing interstitial lung diseases: a national database study in Japan
por: Urushiyama, Hirokazu, et al.
Publicado: (2022) -
Reduction in exacerbation of COPD in patients of advanced age using the Japanese Kampo medicine Dai-kenchu-to: a retrospective cohort study
por: Jo, Taisuke, et al.
Publicado: (2018) -
Use of Recombinant Human Soluble Thrombomodulin in Patients with Sepsis-Induced Disseminated Intravascular Coagulation after Intestinal Perforation
por: Tagami, Takashi, et al.
Publicado: (2015)